Literature DB >> 31909444

Multimodal assessment of white matter microstructure in antipsychotic-naïve schizophrenia patients and confounding effects of recreational drug use.

Jayachandra M Raghava1,2, René C W Mandl3,4, Mette Ø Nielsen3,5, Birgitte Fagerlund3,6, Birte Y Glenthøj3,5, Egill Rostrup3,7, Bjørn H Ebdrup3,5.   

Abstract

Cerebral white matter (WM) aberrations in schizophrenia have been linked to multiple neurobiological substrates but the underlying mechanisms remain unknown. Moreover, antipsychotic treatment and substance use constitute potential confounders. Multimodal studies using diffusion tensor imaging (DTI) and magnetization transfer imaging (MTI) may provide deeper insight into the whole brain WM pathophysiology in schizophrenia. We combined DTI and MTI to investigate WM integrity in 51 antipsychotic-naïve, first-episode schizophrenia patients and 55 matched healthy controls, using 3 T magnetic resonance imaging (MRI). Psychopathology was assessed with the positive and negative syndrome scale (PANSS). A whole brain partial least squares correlation (PLSC) method was used to conjointly analyze DTI-derived measures (fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD), mode of anisotropy (MO)) and the magnetization transfer ratio (MTR) to identify group differences, and associations with psychopathology. In secondary analyses, we excluded recreational substance users from both groups resulting in 34 patients and 51 healthy controls. The primary PLSC group difference analysis identified a significant pattern of lower FA, AD, MO and higher RD in patients (p = 0.04). This pattern suggests disorganized WM microstructure in patients. The secondary PLSC group difference analysis without recreational substance users revealed a significant pattern of lower FA and higher AD, RD, MO, MTR in patients (p = 0.04). This pattern in the substance free patients is consistent with higher extracellular free-water concentrations, which may reflect neuroinflammation. No significant associations with psychopathology were observed. Recreational substance use appears to be a confounding issue, which calls for attention in future WM studies.

Entities:  

Keywords:  Antipsychotic-naïve; Diffusion tensor imaging; MRI; Magnetization transfer; Schizophrenia; White matter

Mesh:

Substances:

Year:  2021        PMID: 31909444     DOI: 10.1007/s11682-019-00230-4

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  65 in total

1.  How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging.

Authors:  Jesper L R Andersson; Stefan Skare; John Ashburner
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

2.  Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images.

Authors:  Daniel B Ennis; Gordon Kindlmann
Journal:  Magn Reson Med       Date:  2006-01       Impact factor: 4.668

3.  Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?

Authors:  Belen Arranz; Gemma Safont; Iluminada Corripio; Nicolas Ramirez; Rosa Maria Dueñas; Victor Perez; Enric Alvarez; Luis San
Journal:  J Dual Diagn       Date:  2015

Review 4.  White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies.

Authors:  Jacob Cookey; Denise Bernier; Philip G Tibbo
Journal:  Schizophr Res       Date:  2014-05-16       Impact factor: 4.939

5.  Abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis.

Authors:  Patricia Alvarado-Alanis; Pablo León-Ortiz; Francisco Reyes-Madrigal; Rafael Favila; Oscar Rodríguez-Mayoral; Humberto Nicolini; Mariana Azcárraga; Ariel Graff-Guerrero; Laura M Rowland; Camilo de la Fuente-Sandoval
Journal:  Schizophr Res       Date:  2015-01-22       Impact factor: 4.939

Review 6.  Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains.

Authors:  Andrew L Alexander; Samuel A Hurley; Alexey A Samsonov; Nagesh Adluru; Ameer Pasha Hosseinbor; Pouria Mossahebi; Do P M Tromp; Elizabeth Zakszewski; Aaron S Field
Journal:  Brain Connect       Date:  2012-01-27

7.  Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.

Authors:  G Bersani; V Orlandi; G D Kotzalidis; P Pancheri
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2002-04       Impact factor: 5.270

8.  DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease.

Authors:  Gwenaëlle Douaud; Saâd Jbabdi; Timothy E J Behrens; Ricarda A Menke; Achim Gass; Andreas U Monsch; Anil Rao; Brandon Whitcher; Gordon Kindlmann; Paul M Matthews; Stephen Smith
Journal:  Neuroimage       Date:  2010-12-21       Impact factor: 6.556

9.  Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use.

Authors:  Denise Bernier; Jacob Cookey; David McAllindon; Robert Bartha; Christopher C Hanstock; Aaron J Newman; Sherry H Stewart; Philip G Tibbo
Journal:  BMC Psychiatry       Date:  2013-10-17       Impact factor: 3.630

Review 10.  Microglia and Brain Plasticity in Acute Psychosis and Schizophrenia Illness Course: A Meta-Review.

Authors:  Livia J De Picker; Manuel Morrens; Steven A Chance; Delphine Boche
Journal:  Front Psychiatry       Date:  2017-11-16       Impact factor: 4.157

View more
  2 in total

1.  Inflammatory Subtypes in Antipsychotic-Naïve First-Episode Schizophrenia are Associated with Altered Brain Morphology and Topological Organization.

Authors:  Dung Hoang; Yanxun Xu; Olivia Lutz; Deepthi Bannai; Victor Zeng; Jeffrey R Bishop; Matcheri Keshavan; Paulo Lizano
Journal:  Brain Behav Immun       Date:  2021-12-04       Impact factor: 7.217

2.  Effectiveness and safety of blonanserin for improving social and cognitive functions in patients with first-episode schizophrenia: a study protocol for a prospective, multicentre, single-arm clinical trial.

Authors:  Chengcheng Pu; Lei Lei; Fude Yang; Hong Deng; Jianhua Sheng; Zhening Liu; Shaohua Hu; Lina Wang; Bin Wu; Qijing Bo; Yoshifumi Inoue; Xin Yu
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.